Skip to main content
Clinical Trials/CTRI/2025/12/098816
CTRI/2025/12/098816Not yet recruitingNot Applicable

A COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFICACY OF CHANGERI GHRITA SUPPOSITORY WITH DICLOFENAC SODIUM SUPPOSITORY IN THE MANAGEMENT OF POST OPERATIVE HAEMORRHOIDECTOMY PAIN.

Shri Shivayogeeshwar Rural Ayurvedic Medical College and Hospital1 site in 1 country40 target enrollmentStarted: December 10, 2026Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
40
Locations
1
Primary Endpoint
Reduction in post-operative pain score measured by Visual Analogur scale (VAS)

Study Overview

Brief Summary

This randomized, parallel-group, active-controlled interventional study aims to compare the efficacy of Changeri Ghrita suppository and Diclofenac sodium (75 mg) suppository in managing post-operative pain following hemorrhoidectomy. 40 patients will be enrolled, with 20 in each group. Changeri Ghrita suppositories will be prepared according to Bhaishajya Ratnavali and administered rectally every 12 hours for five days, while Diclofenac suppositories will be administered similarly. The primary outcome is reduction in post-operative pain measured by Visual Analog Scale (VAS). Secondary outcomes include tenderness, burning sensation, duration of pain relief, recurrence, and rescue analgesic use.

This study seeks to determine whether Changeri Ghrita suppository is a safe and effective alternative to standard Diclofenac suppository for post-hemorrhoidectomy pain management.

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
None

Eligibility Criteria

Ages
20.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Patients undergoing Haemorrhoidectomy .
  • Patients between the age group of 20-60 years.
  • Irrespective of gender and occupations.
  • Controlled Diabetic and Hypertensive patients will be selected for the study.

Exclusion Criteria

  • Patient suffering from systemic diseases like Uncontrolled Diabeties and Hypertention, Tuberculosis, Rheumatoid arthritis.
  • patients with haemorrhoids with IBS and Crohns disease.
  • Postive cases of HIV, VDRL,Hepatitis B, Leprosy.Post operative cases with complications like Severe bleeding , wound sepsis .
  • Cases of Haemorrhoids with fissure, fistula in ano, ischio rectal abscess , perianal abscess and CA Rectum.

Outcomes

Primary Outcomes

Reduction in post-operative pain score measured by Visual Analogur scale (VAS)

Time Frame: at baseline (0 hrs), 12 hrs, 24 hrs, 48 hrs,72 hrs,96hrs and 120 hrs

Secondary Outcomes

  • Burning pain at site of insertion -(Grade 1-present)
  • Tendernessat operative site measured clinically as(Grade1- present)
  • Duration of pain reduction (after suppository insertion)(Grade1- reduction after 30 mins)
  • Reoccurence of pain(Grade 1- no pain)
  • Rescue analgesic requirement yes or no(number of dose required)

Investigators

Sponsor
Shri Shivayogeeshwar Rural Ayurvedic Medical College and Hospital
Sponsor Class
Private medical college
Responsible Party
Principal Investigator
Principal Investigator

RAHUL GASTI

SHRI SHIVAYOGEESHWAR RURAL AYURVEDIC MEDICAL COLLEGE AND HOSPTIAL, INCHAL

Study Sites (1)

Loading locations...

Similar Trials